Key facts
- It has raised $860K across 1 recorded rounds; the latest was Seed Round ($1.0M) in Aug 2025.
- Notable investors include Character (VC).
- Mediphant has filed 4 Form Ds with the SEC, most recently Sep 2025 ($100K sold to 1 investors).
- Status: Privately Held (backing).
Investors
1- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Mediphant
Funding rounds
1 roundsAbout Mediphant
Developer of an AI-powered healthcare confidant platform designed to help patients manage and understand their medical data. The company's platform offers features such as answering health questions based on medical data, confidential chat with an AI chatbot, tracking of symptoms, metrics, and medical events, and more, enabling users to get personalized health insights instead of spending hours researching on Google or waiting for appointments to ask simple questions.
- Sector
- Healthcare
- HQ
- Dallas, TX, United States
- Founded
- 2025
- Employees
- 3
- Website
- mediphant.ai/
- Ownership
- Privately Held (backing)
Mediphant doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Mediphant shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Mediphant in its N-PORT filings yet. We sweep new filings monthly.